Tokyo, Japan

Nakako Arao


Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Tokyo, JP (2003 - 2006)
  • Itabashi-ku, JP (2006)

Company Filing History:


Years Active: 2003-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nakako Arao: Innovator in Microbiology and Oncology

Introduction

Nakako Arao is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the fields of microbiology and oncology, holding a total of 4 patents. Her innovative work focuses on novel microorganisms and their applications in health and beauty.

Latest Patents

One of her latest patents involves a novel microorganism, specifically the B20 strain, which produces (E)-4-(2-isocyanovinyl)phenyl α-rhamnopyranoside. This compound has been shown to inhibit melanogenesis effectively. The microorganism is a gram-negative bacillus isolated from soil, exhibiting motility due to its polar flagellum. The α-L-rhamnopyranoside produced by culturing this microorganism under specific conditions serves as a highly safe and stable whitening agent. Another significant patent is for a depsipeptide compound that possesses cytotoxic activity and TGF-β-like activity against human cancer cells. This compound is useful as an antitumor agent and is included in a pharmaceutical composition.

Career Highlights

Throughout her career, Nakako Arao has worked with notable companies such as Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.

Collaborations

She has collaborated with esteemed colleagues, including Koji Nagai and Kazuma Kamigiri. These partnerships have fostered a creative environment that has led to groundbreaking discoveries in her field.

Conclusion

Nakako Arao's contributions to microbiology and oncology highlight her role as a leading inventor. Her innovative patents and collaborations reflect her commitment to advancing science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…